Advertisement

Topics

Latest "Auxilium" News Stories

04:22 EST 16th December 2017 | BioPortfolio

Here are the most relevant search results for "Auxilium" found in our extensive news archives from over 250 global news sources.

More Information about Auxilium on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Auxilium for you to read. Along with our medical data and news we also list Auxilium Clinical Trials, which are updated daily. BioPortfolio also has a large database of Auxilium Companies for you to search.

Showing "Auxilium" News Articles, all 6

Friday 17th November 2017

Endo unit cleared of liability in first testosterone replacement trial

NEW YORK: A federal jury in Chicago said on Thursday that Endo International's Auxilium unit was not responsible for the heart attack a man suffered while using the company's testosterone replacement drug Testim. The verdict was a victory for the drugmaker in its first trial over allegations it defectively designed Testim, a skin gel, and negligently misrepresented its risks.


Tuesday 7th November 2017

Kala Pharmaceuticals Reports Third Quarter 2017 Financial Results And Provides Business Update

Completed Initial Public Offering Raising $103.5 million in gross proceeds Submitted New Drug Application to U.S. Food and Drug Administration for INVELTYS™ (KPI-121 1%) Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of product candidates using its proprietary muc...

Friday 20th October 2017

Fortress Biotech (FBIO) & Auxilium Pharmaceuticals (AUXL) Critical Comparison

Fortress Biotech and Auxilium Pharmaceuticals are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, profitability, risk, institutional ownership and analyst recommendations. This is a breakdown of current ratings and price targets for Fortress Biotech and Auxilium Pharmaceuticals, as report...


Monday 2nd October 2017

Kala Pharmaceuticals Appoints Andrew I. Koven to Board of Directors

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of product candidates using its proprietary mucus-penetrating particle (MPP) technology, today announced the appointment of Andrew I. Koven to the Company’s Board of Directors. Mr. Koven will serve as a Class I director and serve on the ...

Friday 8th September 2017

Financial Survey: Auxilium Pharmaceuticals

Auxilium Pharmaceuticals and Alimera Sciences are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, risk, earnings, analyst recommendations and profitability. This is a breakdown of current ratings and recommmendations for Auxilium Pharmaceuticals and Alimera Sciences, as...

Sunday 20th August 2017

BioSpecifics Technologies Corp BSTC Financial and Strategic SWOT Analysis Review [Report Updated: 12072017] Prices from USD $125

BioSpecifics Technologies Corp BSTC Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies tha...


Quick Search
Advertisement
 

News Quicklinks